Honduras

Reimbursed Care Access

Honduras maintains criminal prohibitions and strict controls on psychoactive and psychotropic substances via its drug laws and Penal Code, which reference international drug-control treaty schedules. Traditional and novel psychedelics (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, mescaline, 2C‑X, ayahuasca preparations) are effectively prohibited for general use and have no routine reimbursed medical pathways outside of tightly controlled research. Ketamine is widely used and legally available as an anesthetic in healthcare settings (not generally reimbursed as a specialized psychiatric therapy); esketamine (Spravato) has global approvals in some markets but there is no public evidence of a Honduran marketing approval or national reimbursement program as of February 20, 2026.